These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37030308)

  • 1. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 3. The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ Open; 2014 Aug; 4(8):e005809. PubMed ID: 25168040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2013 Aug; 3(8):e003482. PubMed ID: 23959760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Sep; 5(9):e008503. PubMed ID: 26353872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2015 Nov; 351():h5441. PubMed ID: 26560308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Jun; 357():j2497. PubMed ID: 28620089
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of first-time traumatic anterior shoulder dislocation: the UK TASH-D cohort study.
    Rees JL; Shah A; Edwards K; Sanchez-Santos MT; Robinson DE; Delmestri A; Carr A; Arden N; Lamb SE; Rangan A; Judge A; Pinedo-Villanueva R; Holt T; Hopewell S; Prieto-Alhambra D; Collins G
    Health Technol Assess; 2019 Apr; 23(18):1-104. PubMed ID: 31043225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
    Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
    Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
    Clift AK; Dodwell D; Lord S; Petrou S; Brady M; Collins GS; Hippisley-Cox J
    BMJ; 2023 May; 381():e073800. PubMed ID: 37164379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study.
    Archer L; Koshiaris C; Lay-Flurrie S; Snell KIE; Riley RD; Stevens R; Banerjee A; Usher-Smith JA; Clegg A; Payne RA; Hobbs FDR; McManus RJ; Sheppard JP;
    BMJ; 2022 Nov; 379():e070918. PubMed ID: 36347531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population.
    Livingstone SJ; Morales DR; McMinn M; Eke C; Donnan P; Guthrie B
    BMJ Med; 2022; 1(1):e000316. PubMed ID: 36936595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
    Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
    Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.